-
Something wrong with this record ?
Cognitive Performance and Exposure to Organophosphate Flame Retardants in Children: Evidence from a Cross-Sectional Analysis of Two European Mother-Child Cohorts
V. Rosolen, E. Giordani, M. Mariuz, M. Parpinel, V. Mustieles, L. Gilles, E. Govarts, L. Rodriguez Martin, K. Baken, G. Schoeters, O. Sepai, E. Sovcikova, L. Fabelova, J. Kohoutek, TK. Jensen, A. Covaci, M. Roggeman, L. Melymuk, J. Klánová, A....
Status not-indexed Language English Country Switzerland
Document type Journal Article
Grant support
733032
European Union
APVV-0571-12
Slovak Research and Development Agency
2014/47-SZU-11
Ministry of Health of the Slovak Republic
4004-00352B_FSS
The Danish Research Council
NNF19OC0058266
Novo Nordisk Foundation, Denmark
NNF17OC0029404
Novo Nordisk Foundation, Denmark
2021-0173
Health Insurance Denmark
NLK
Directory of Open Access Journals
from 2013
PubMed Central
from 2015
Europe PubMed Central
from 2015
ProQuest Central
from 2013-01-01
Open Access Digital Library
from 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2013
- Publication type
- Journal Article MeSH
The knowledge of the effects of organophosphate flame retardants on children's neurodevelopment is limited. The purpose of the present research is to evaluate the association between exposure to organophosphate flame retardants and children's neurodevelopment in two European cohorts involved in the Human Biomonitoring Initiative Aligned Studies. The participants were school-aged children belonging to the Odense Child Cohort (Denmark) and the PCB cohort (Slovakia). In each cohort, the children's neurodevelopment was assessed through the Full-Scale Intelligence Quotient score of the Wechsler Intelligence Scale for Children, using two different editions. The children's urine samples, collected at one point in time, were analyzed for several metabolites of organophosphate flame retardants. The association between neurodevelopment and each organophosphate flame retardant metabolite was explored by applying separate multiple linear regressions based on the approach of MM-estimation in each cohort. In the Danish cohort, the mean ± standard deviation for the neurodevelopment score was 98 ± 12; the geometric mean (95% confidence interval (95% CI)) of bis(1,3-dichloro-2-propyl) phosphate (BDCIPP) standardized by creatinine (crt) was 0.52 μg/g crt (95% CI = 0.49; 0.60), while that of diphenyl phosphate (DPHP) standardized by crt was 1.44 μg/g crt (95% CI = 1.31; 1.58). The neurodevelopment score showed a small, negative, statistically imprecise trend with BDCIPP standardized by crt (β = -1.30; 95%CI = -2.72; 0.11; p-value = 0.07) and no clear association with DPHP standardized by crt (β = -0.98; 95%CI = -2.96; 0.99; p-value = 0.33). The neurodevelopment score showed a negative trend with BDCIPP (β = -1.42; 95% CI = -2.70; -0.06; p-value = 0.04) and no clear association with DPHP (β = -1.09; 95% CI = -2.87; 0.68; p-value = 0.23). In the Slovakian cohort, the mean ± standard deviation for the neurodevelopment score was 81 ± 15; the geometric mean of BDCIPP standardized by crt was 0.18 μg/g crt (95% CI = 0.16; 0.20), while that of DPHP standardized by crt was 2.24 μg/g crt (95% CI = 2.00; 3.52). The association of the neurodevelopment score with BDCIPP standardized by crt was -0.49 (95%CI = -1.85; 0.87; p-value = 0.48), and with DPHP standardized by crt it was -0.35 (95%CI = -1.90; 1.20; p-value = 0.66). No clear associations were observed between the neurodevelopment score and BDCIPP/DPHP concentrations that were not standardized by crt. No clear associations were observed with bis(1-chloro-2-propyl) phosphate (BCIPP) in either cohort, due to the low detection frequency of this compound. In conclusion, this study provides only limited evidence of an inverse association between neurodevelopment and exposure to BDCIPP and DPHP. The timing of exposure and effect modification of other organophosphate flame retardant metabolites and other substances should be the subject of further investigations that address this scientific hypothesis.
BrabantAdvies Brabantlaan 3 5216 TV 's Hertogenbosch The Netherlands
Center for Biomedical Research University of Granada 18012 Granada Spain
Consortium for Biomedical Research in Epidemiology and Public Health 28029 Madrid Spain
Department of Medicine University of Udine Via Colugna 50 33100 Udine Italy
Instituto de Investigación Biosanitaria de Granada 18012 Granada Spain
National Centre for Environmental Health Instituto de Salud Carlos 3 28220 Majadahonda Spain
RECETOX Faculty of Science Masaryk University Kotlářská 2 611 37 Brno Czech Republic
Toxicological Centre University of Antwerp Wilrijk 2610 Antwerp Belgium
VITO Health Flemish Institute for Technological Research 2400 Mol Belgium
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23022657
- 003
- CZ-PrNML
- 005
- 20240116163111.0
- 007
- ta
- 008
- 240105s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/toxics11110878 $2 doi
- 035 __
- $a (PubMed)37999530
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Rosolen, Valentina $u Central Directorate for Health, Social Policies and Disability, Friuli Venezia Giulia Region, Via Cassa Di Risparmio 10, 34121 Trieste, Italy $1 https://orcid.org/0000000312925564
- 245 10
- $a Cognitive Performance and Exposure to Organophosphate Flame Retardants in Children: Evidence from a Cross-Sectional Analysis of Two European Mother-Child Cohorts / $c V. Rosolen, E. Giordani, M. Mariuz, M. Parpinel, V. Mustieles, L. Gilles, E. Govarts, L. Rodriguez Martin, K. Baken, G. Schoeters, O. Sepai, E. Sovcikova, L. Fabelova, J. Kohoutek, TK. Jensen, A. Covaci, M. Roggeman, L. Melymuk, J. Klánová, A. Castano, M. Esteban López, F. Barbone
- 520 9_
- $a The knowledge of the effects of organophosphate flame retardants on children's neurodevelopment is limited. The purpose of the present research is to evaluate the association between exposure to organophosphate flame retardants and children's neurodevelopment in two European cohorts involved in the Human Biomonitoring Initiative Aligned Studies. The participants were school-aged children belonging to the Odense Child Cohort (Denmark) and the PCB cohort (Slovakia). In each cohort, the children's neurodevelopment was assessed through the Full-Scale Intelligence Quotient score of the Wechsler Intelligence Scale for Children, using two different editions. The children's urine samples, collected at one point in time, were analyzed for several metabolites of organophosphate flame retardants. The association between neurodevelopment and each organophosphate flame retardant metabolite was explored by applying separate multiple linear regressions based on the approach of MM-estimation in each cohort. In the Danish cohort, the mean ± standard deviation for the neurodevelopment score was 98 ± 12; the geometric mean (95% confidence interval (95% CI)) of bis(1,3-dichloro-2-propyl) phosphate (BDCIPP) standardized by creatinine (crt) was 0.52 μg/g crt (95% CI = 0.49; 0.60), while that of diphenyl phosphate (DPHP) standardized by crt was 1.44 μg/g crt (95% CI = 1.31; 1.58). The neurodevelopment score showed a small, negative, statistically imprecise trend with BDCIPP standardized by crt (β = -1.30; 95%CI = -2.72; 0.11; p-value = 0.07) and no clear association with DPHP standardized by crt (β = -0.98; 95%CI = -2.96; 0.99; p-value = 0.33). The neurodevelopment score showed a negative trend with BDCIPP (β = -1.42; 95% CI = -2.70; -0.06; p-value = 0.04) and no clear association with DPHP (β = -1.09; 95% CI = -2.87; 0.68; p-value = 0.23). In the Slovakian cohort, the mean ± standard deviation for the neurodevelopment score was 81 ± 15; the geometric mean of BDCIPP standardized by crt was 0.18 μg/g crt (95% CI = 0.16; 0.20), while that of DPHP standardized by crt was 2.24 μg/g crt (95% CI = 2.00; 3.52). The association of the neurodevelopment score with BDCIPP standardized by crt was -0.49 (95%CI = -1.85; 0.87; p-value = 0.48), and with DPHP standardized by crt it was -0.35 (95%CI = -1.90; 1.20; p-value = 0.66). No clear associations were observed between the neurodevelopment score and BDCIPP/DPHP concentrations that were not standardized by crt. No clear associations were observed with bis(1-chloro-2-propyl) phosphate (BCIPP) in either cohort, due to the low detection frequency of this compound. In conclusion, this study provides only limited evidence of an inverse association between neurodevelopment and exposure to BDCIPP and DPHP. The timing of exposure and effect modification of other organophosphate flame retardant metabolites and other substances should be the subject of further investigations that address this scientific hypothesis.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Giordani, Elisa $u Department of Medicine, University of Udine, Via Colugna 50, 33100 Udine, Italy $1 https://orcid.org/0000000235999462
- 700 1_
- $a Mariuz, Marika $u Department of Medicine, University of Udine, Via Colugna 50, 33100 Udine, Italy
- 700 1_
- $a Parpinel, Maria $u Department of Medicine, University of Udine, Via Colugna 50, 33100 Udine, Italy $1 https://orcid.org/0000000313094467
- 700 1_
- $a Mustieles, Vicente $u Center for Biomedical Research, University of Granada, 18012 Granada, Spain $u Instituto de Investigación Biosanitaria de Granada, 18012 Granada, Spain $u Consortium for Biomedical Research in Epidemiology and Public Health, 28029 Madrid, Spain $1 https://orcid.org/0000000220105438
- 700 1_
- $a Gilles, Liese $u VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium $1 https://orcid.org/0000000230169750
- 700 1_
- $a Govarts, Eva $u VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium $1 https://orcid.org/0000000260754862
- 700 1_
- $a Rodriguez Martin, Laura $u VITO Health, Flemish Institute for Technological Research (VITO), 2400 Mol, Belgium
- 700 1_
- $a Baken, Kirsten $u BrabantAdvies, Brabantlaan 3, 5216 TV 's-Hertogenbosch, The Netherlands
- 700 1_
- $a Schoeters, Greet $u Department of Biomedical Sciences & Toxicological Centre, University of Antwerp-Campus Drie Eiken, Universiteitsplein 1, Wilrijk, 2610 Antwerp, Belgium $1 https://orcid.org/0000000265564814
- 700 1_
- $a Sepai, Ovnair $u Toxicology Department, Science Group, UK Health Security Agency, Harwell Science and Innovation Campus, Didcot OX11 0RQ, UK
- 700 1_
- $a Sovcikova, Eva $u Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 83303 Bratislava, Slovakia
- 700 1_
- $a Fabelova, Lucia $u Department of Environmental Medicine, Faculty of Public Health, Slovak Medical University, 83303 Bratislava, Slovakia $1 https://orcid.org/0000000266339096
- 700 1_
- $a Kohoutek, Jiři $u RECETOX, Faculty of Science, Masaryk University, Kotlářská 2, 611 37 Brno, Czech Republic
- 700 1_
- $a Jensen, Tina Kold $u Department of Clinical Pharmacology, Pharmacy and Environmental Medicine, Institute of Public Health, University of Southern Denmark, 5000 Odense, Denmark
- 700 1_
- $a Covaci, Adrian $u Toxicological Centre, University of Antwerp, Wilrijk, 2610 Antwerp, Belgium $1 https://orcid.org/0000000305271136
- 700 1_
- $a Roggeman, Maarten $u Toxicological Centre, University of Antwerp, Wilrijk, 2610 Antwerp, Belgium
- 700 1_
- $a Melymuk, Lisa $u RECETOX, Faculty of Science, Masaryk University, Kotlářská 2, 611 37 Brno, Czech Republic $1 https://orcid.org/0000000160427688
- 700 1_
- $a Klánová, Jana $u RECETOX, Faculty of Science, Masaryk University, Kotlářská 2, 611 37 Brno, Czech Republic
- 700 1_
- $a Castano, Argelia $u National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Majadahonda, Spain $1 https://orcid.org/0000000341527119
- 700 1_
- $a Esteban López, Marta $u National Centre for Environmental Health, Instituto de Salud Carlos III, 28220 Majadahonda, Spain $1 https://orcid.org/000000024527350X
- 700 1_
- $a Barbone, Fabio $u Department of Medicine, Surgery and Health Sciences, University of Trieste, Strada di Fiume, 447, 34149 Trieste, Italy
- 773 0_
- $w MED00196874 $t Toxics $x 2305-6304 $g Roč. 11, č. 11 (2023)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37999530 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240105 $b ABA008
- 991 __
- $a 20240116163108 $b ABA008
- 999 __
- $a ok $b bmc $g 2036352 $s 1209102
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 11 $c 11 $e 20231024 $i 2305-6304 $m Toxics $n Toxics $x MED00196874
- GRA __
- $a 733032 $p European Union
- GRA __
- $a APVV-0571-12 $p Slovak Research and Development Agency
- GRA __
- $a 2014/47-SZU-11 $p Ministry of Health of the Slovak Republic
- GRA __
- $a 4004-00352B_FSS $p The Danish Research Council
- GRA __
- $a NNF19OC0058266 $p Novo Nordisk Foundation, Denmark
- GRA __
- $a NNF17OC0029404 $p Novo Nordisk Foundation, Denmark
- GRA __
- $a 2021-0173 $p Health Insurance Denmark
- LZP __
- $a Pubmed-20240105